Skip to Content

Sodium Chloride 0.9% Injection

This page contains information on Sodium Chloride 0.9% Injection for veterinary use.
The information provided typically includes the following:
  • Sodium Chloride 0.9% Injection Indications
  • Warnings and cautions for Sodium Chloride 0.9% Injection
  • Direction and dosage information for Sodium Chloride 0.9% Injection

Sodium Chloride 0.9% Injection

This treatment applies to the following species:
Manufacturer: Aspen

STERILE NONPYROGENIC SOLUTION

For Animal Use Only

KEEP OUT OF REACH OF CHILDREN

Description

Sodium Chloride 0.9% Injection is a sterile, nonpyrogenic solution intended for water and electrolytes replenishment in single dose containers. May be administered intravenously using aseptic technique. It contains no antimicrobial agents. Discard any unused portion. Composition, osmolarity, pH and ionic concentration are shown in Table 1.

Table 1

Composition (g/L)

Osmolarity (mOsmol/L) (calc)

pH

Ionic Concentration (mEq/L)

Sodium Chloride NaCl

Sodium

Chloride

9.0

308

5.5 (4 - 7)

150

150

The container is free of PVC and phthalates. The container meets the requirements of USP and is registered with FDA.

Clinical Pharmacology

Sodium Chloride 0.9% Injection is intended to restore water and electrolytes. It is capable of inducing diuresis, depending on the clinical condition of the patient.

Sodium Chloride 0.9% Injection Indications

Sodium Chloride 0.9% Injection is indicated as a source of water and electrolytes.

Contraindications

None known.

Warnings

Sodium Chloride 0.9% Injection should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema with sodium retention.

The intravenous administration of Sodium Chloride 0.9% Injection can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, over-hydration, congested states, or pulmonary edema. The risk of dilutive states is inversely proportional to the electrolyte concentration of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections.

In patients with diminished renal function, administration of Sodium Chloride 0.9% Injection may result in sodium retention.

Adverse Reactions

Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

Precautions

This is a single dose unit. It contains no preservatives. Use entire contents when first opened.

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.

Caution must be exercised in the administration of Sodium Chloride 0.9% Injection to patients receiving corticosteroids or corticotropin.

Do not administer unless solution is clear and seal is intact.

Solution must be warmed to body temperature prior to administration at a slow rate. Use solution promptly following initial entry.

Reactions which may occur because of the solution or the technique of administration, include febrile response, infection at the site of injection, extravasation, and hypervolemia.

Dosage and Administration

As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient, as well as laboratory determinations.

Parenteral drug products should be inspected visually for particulate matter and discolouration prior to administration whenever solution and container permit.

Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Mix thoroughly when additives have been introduced. Do not store solutions containing additives.

Over-dosage

In an event of over-hydration or solute overload, reevaluate the patient and institute appropriate corrective measures. See Warnings, Precautions and Adverse Reactions.

Storage

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (86°F/30°C). Protect from freezing.

Directions for use of plastic container

To Open

Tear overwrap at slit and remove solution container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing solution container firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below:

Preparation for Administration

1. Suspend container from eyelet support.

2. Remove plastic protector from inlet/outlet port at bottom of container.

3. Attach administration set.

To Add Medication

WARNING: Additives may be incompatible.

To add medication before solution administration

1. Prepare medication site.

2. Using syringe with 0.63mm to 0.80mm needle, puncture medication port and inject.

3. Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.

To add medication during solution administration

1. Close the clamp on the administration set.

2. Prepare medication site.

3. Using syringe with 0.63mm to 0.80mm needle, puncture medication port and inject.

4. Remove container from IV pole and/or turn to an upright position.

5. Evacuate both ports by squeezing them while container is in the upright position.

6. Mix solution and medication thoroughly.

7. Return container to in use position and continue administration.

Sodium Chloride 0.9% Injection Caution

FEDERAL LAW RESTRICTS THIS DRUG TO USE BY OR ON THE ORDER OF A LICENSED VETERINARIAN.

Manufactured for: Aspen Veterinary Resources® Ltd., Liberty, MO 64068, USA

www.aspenveterinaryresources.com

Manufactured by: Sypharma Pty Ltd, 27 Healey Road, Dandenong, Victoria 3175 Australia

For customer service email: info@aspenveterinaryresources.com

Rev. 04/16

 

NDC NUMBER:

 

250 mL (8.45 fl oz)

46066-512-04

A533SPH

REV. 04/16

500 mL (16.91 fl oz)

46066-512-05

A534SPH

REV. 04/16

1000 mL (33.81 fl oz)

46066-512-06

A535SPH

REV. 04/16

CPN: 1475356.0

ASPEN VETERINARY RESOURCES, LTD.
3155 W. HEARTLAND DRIVE, LIBERTY, MO, 64068
Telephone:   816-415-4324
Fax:   816-415-4314
Website:   www.aspenveterinaryresources.com
Every effort has been made to ensure the accuracy of the Sodium Chloride 0.9% Injection information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2017 North American Compendiums. Updated: 2017-11-28

Hide